期刊文献+

HSV-TK/GCV联合IL-2治疗舌癌移植瘤的机制探讨

Research of treatment for experimented human lingual squamous cell carcinoma by union treatment with HSV-TK and IL-2
下载PDF
导出
摘要 目的:观察HSV-TK联合IL-2对舌癌细胞的生长抑制作用,并探讨HSV-TK与IL-2联合应用对舌癌抑制和杀伤的机制。方法:建立舌癌Tca8113移植瘤动物模型,采用HSV-TK联合IL-2对移植瘤进行体内转染,观察肿瘤生长情况。使用RT-PCR检测HSV-TK基因和IL-2基因的表达情况;应用流式细胞仪检测移植瘤的凋亡情况;采用免疫组化法检测移植瘤中CD4和CD8蛋白的表达情况。结果:移植瘤体积生长曲线表明TK组(C组)及TK联合IL-2组(D组)肿瘤的生长明显受到抑制。TK组抑瘤率为40.1%,TK联合IL-2组抑瘤率为80.2%。RT-PCR检测目的基因HSV-TK基因和IL-2基因已整合入肿瘤细胞中且稳定表达。流式细胞仪检测A组(对照组)和B组(病毒组)凋亡峰不明显,而C组和D组凋亡峰明显。对照组、病毒组、TK组、TK联合IL-2组凋亡率分别为(6.77±1.31)、(7.08±1.28)、(13.22±3.28)、(28.90±6.50)。除对照组、病毒组无明显差异(P>0.05),其他任2组之间比较均有显著性差异(P<0.01)。在TK联合IL-2组,肿瘤细胞周围有大量CD4和CD8阳性的淋巴细胞浸润。结论:HSV-TK和IL-2治疗后可显著抑制Tca8113移植瘤的生长。HSV-TK与IL-2基因联合应用,其治疗效果较单独应用HSV-TK明显提高。HSV-TK可明显杀伤Tca8113移植瘤细胞,而IL-2可以诱导机体抗肿瘤免疫反应。 Objective:To observe the depressing effects on tongue cancer by union treatment with HSV-TK and IL-2 and to discuss its depressing mechanism.Methods:Tca8113 lingual cancer animal models were set up.In vivo experiment was done on planting tumors with HSV-TK and IL-2 gene.The tumor volumes were measured from the beginning of the experiment.Expressions of HSV-TK and IL-2 gene were detected by RT-PCR.The percentage of apoptotic cells was detected by flow cytometer.Immmunohistochemistry against CD4 and CD8 antibodies were also investigated.Results:From the growth curve of volume change of transplanted tumors,the growth of the transplanted tumors in TK group and TK/IL-2 group was inhibited.The ratio of tumor inhibition of TK group was 40.1% and that of TK/IL-2 group was 80.2%.Results of RT-PCR showed that HSV-TK gene and IL-2 gene had been transferred into tumor cells and expressed.Results of flow cytometer showed that typical apoptotic peak was formed in TK and TK/IL-2 groups.The percentage of apoptotic cells:(6.77±1.31)% in control group,(7.08±1.28)% in empty virus group,(13.22±3.28)% in TK group,and(28.90±6.50)% in group TK/IL-2 group.There was significant difference between groups(P〈0.01),except group A and B(P〉0.05).In TK/IL-2 group,many lymphocytes with CD4 and CD8 positive around tumor cells were found.Conclusion:HSV-TK/GCV system and IL-2 could suppress the growth of Tca8113 transplanted tumors in the nude mice.The effect of HSV-TK with IL-2 on Tca8113 transplanted tumors was better than that of HSV-TK/GCV alone.HSV-TK/GCV system can kill Tca8113 cells and IL-2 could induce immunologic reaction against tumor.
出处 《实用口腔医学杂志》 CAS CSCD 北大核心 2008年第2期261-265,共5页 Journal of Practical Stomatology
关键词 鳞状细胞癌 HSV-TK IL-2 裸鼠 移植瘤 Squamous cell carcinoma Tongue HSV-TK/GCV IL-2 Nude mice Transplanted tumors
  • 相关文献

参考文献11

  • 1Majumdar AS, Zolotorev A, Samuel S, et al. Efficacy of herpes simplex virus thymidine kinase in combination with cytokine gene therapy in an experimental metastatic breast cancer model [ J ]. Cancer Gene Ther,2000,7 (7) :1086 -1099.
  • 2Colombo F, Barzon L, Franchin E, et al. Combined HSV- TK/IL-2 gene therapy in patients with recurrent glioblastoma muhiforme: Biological and clinical results [ J ]. Cancer Gene Ther,2005,12(10) :835 - 848.
  • 3孙春晓,何荣根,张志愿,刘兴坤,周晓健,陈诗书.涎腺腺样囊性癌自杀基因治疗的实验研究[J].中华口腔医学杂志,2000,35(1):34-37. 被引量:4
  • 4郑书深,王洁,董福生,董玉英,侯亚丽.HSV-tK与IL-2基因对涎腺多形性腺瘤细胞的杀伤作用[J].中国肿瘤临床,2005,32(10):544-547. 被引量:1
  • 5王旭,王洁,董福生,董玉英,侯亚丽.HSV-tk与p53基因对涎腺多形性腺瘤细胞的杀伤作用[J].华西口腔医学杂志,2005,23(1):65-68. 被引量:3
  • 6Su H, Lu R, Ding R,et al. Adeno-associated viral-mediated gene transfer to hepatoma: Thymidine kinase/interleukin 2 is more effective in tumor killing in non-ganciclovir (GCV)- treated than in GCV-treated animals [ J ]. Mol Ther, 2000, 1 (6) :509 -515.
  • 7Kwong KY, Zou Y, Day CP,et al. The suppression of colon cancer cell growth in nude mice by targeting beta-catenin/ TCF pathway [ J ]. Oncogene,2002,21 (54) : 8340 - 8346.
  • 8Sun CX, He RG, Cheung LK. The biological behaviour of human adenoid cystic carcinoma cells transduced with interleukin-2-gene[ J]. Int J Oral Maxillofac Surg, 2002,31 (6) : 650 - 656.
  • 9Uhl M, Weiler M, Wick W, et al. Migratory neural stem cells for improved thymidine kinase-based gene therapy of malignant gliomas [ J ]. Biochem Biophys Res Commun, 2005,328( 1 ) : 125 - 129.
  • 10Majumdar AS, Zolotorev A, Samuel S, et al. Efficacy of herpes simplex virus thymidine kinase in combination with cytokine gene therapy in an experimental metastatic breast cancer model [ J ]. Cancer Gene Ther, 2000,7 ( 7 ) : 1086 - 1089.

二级参考文献19

  • 1Maatta AM, Tenhunen A, Pasanen T, et al. Non-small cell lung can-cer as a target disease for herpes simplex type 1 thymidine kinase-gan-ciclovir gene therapy[J], Int J Oncol, 2004, 24(4): 943-949.
  • 2Hoggarth JH, Jones E, Ensser A. Functional expression of thymidine kinase in human leukaemic and colorectal cells, delivered as EGFP fu-sion protein by herpesvirus saimiri-based vector [ J ]. Cancer GeneTher, 2004,11(7): 512-518.
  • 3Matsubara H, Kawanmra K, Sugaya M, et al. Differential efficacy of suicide gene therapy by herpes simplex virus-thymidine kinase gene re-flects the status of p53 gene in human esophageal cancer cells[J]. An-ticancer Res, 1999, 19(5B): 4157-4160.
  • 4Pisters EL, Pettaway CA, Tronccso P, et al. Evidence that trander of functional p53 protein results in increased apoptosis in prostate cancer[J]. Clin Cancer Res, 2004,10(8) : 2587-2593.
  • 5Ketola A, Maatta AM, Pasanen T, et al. Osteosarconma and chondro-sarcoma as targets for virus vectors and herpes simplex virus thymidine kinase/ganciclovir gene therapy[J], Int J Mol Med, 2004, 13(5):705-710.
  • 6Bi W,Cancer Gene Therapy,1997年,4卷,246页
  • 7Rogulski K R,Clin Cancer Res,1997年,3卷,2081页
  • 8Su H,Proc Nat Acad Sci SUA,1997年,94卷,13891页
  • 9O'Malley B W,Cancer Res,1996年,56卷,1737页
  • 10Matsubara H, Kawamura K, Sugaya M, et al. Differential efficacy of suicide gene therapy by herpes simplex virus-thymidine kinase gene reflects the status of IL-2 gene in human esophageal cancer cells[J]. Anticancer Res, 1999, 19(2):4157-4160

共引文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部